TFRC and neoplasm: Whether this Fc-mediated activity is due to ADCC/ADCP and/or if there is a contribution of the inhibition of internalization of TfR1 into cancer cells when the antibody is simultaneously bound to FcγRs on immune cells in the tumor microenvironment remains to be determined.